REG - Applied Nutrition - Result of AGM

Applied NutritionAnnouncement

08/01/2026 13:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260108:nRSH2159Oa&default-theme=true

RNS Number : 2159O  Applied Nutrition PLC  08 January 2026

8(th) January 2026

Applied Nutrition plc

Results of Annual General Meeting

 

Applied Nutrition plc (Company), a leading sports nutrition, health and
wellness brand, announces that at the Company's Annual General Meeting held at
11:00 a.m. on 8 January 2026 (AGM), all resolutions set out in the notice of
AGM (Notice) were duly passed by the requisite majority of shareholder votes
by way of a poll. Resolutions 1 to 14 were passed as ordinary resolutions and
resolutions 15 to 18 were passed as special resolutions. The full text of the
resolutions can be found in the Notice which is available on the Company's
website at:
https://www.appliednutritionplc.com/results-reports-and-presentations/
(https://www.appliednutritionplc.com/results-reports-and-presentations/)

The results of the poll were as follows:

 No.  Resolution                                                                      For                 Against                  Votes Withheld    Total issued share capital instructed

      Number of shares                                                                             %      Number of shares  %      Number of shares  %
 1    To receive the Annual Report and Accounts of the Company for the year ended 31  202,617,005  99.61  787,013           0.39   21,686            81.36
      July 2025 together with the Directors' reports and auditor's report on those
      accounts.
 2    To approve the Directors' Remuneration Report for the financial year ended 31   203,086,274  99.84  319,075           0.16   20,355            81.36
      July 2025 as set out on pages 66 to 81 of the Company's Annual Report and
      Accounts for the year ended 31 July 2025 (excluding the Directors'
      Remuneration Policy).
 3    To approve the Directors' Remuneration Policy as set out on pages 68 to 76 of   201,567,124  99.1   1,837,229         0.9    21,351            81.36
      the Company's Annual Report and Accounts for the year ended 31 July 2025 to
      take effect immediately following the AGM.
 4    To elect Andy Bell as a director of the Company.                                201,090,257  98.86  2,318,054         1.14   17,393            81.36
 5    To elect Tony Buffin as a director of the Company.                              201,976,560  99.3   1,423,111         0.7    26,033            81.36
 6    To elect Peter Cowgill as a director of the Company.                            201,082,987  99.16  1,696,823         0.84   645,894           81.11
 7    To elect Steven Granite as a director of the Company.                           203,241,692  99.92  166,313           0.08   17,699            81.36
 8    To elect Marnie Millard as a director of the Company.                           201,896,810  99.26  1,510,794         0.74   18,100            81.36
 9    To elect Joe Pollard as a director of the Company.                              203,245,310  99.92  162,294           0.08   18,100            81.36
 10   To elect Thomas Ryder as a director of the Company.                             203,276,763  99.93  133,304           0.07   15,637            81.36
 11   To elect Deepti Velury Bakhshi as a director of the Company.                    203,400,669  99.99  7,336             0.01   17,699            81.36
 12   To re-appoint BDO LLP as auditor of the Company to hold office until the        203,412,750  99.99  7,427             0.01   5,527             81.37
      conclusion of the next general meeting at which accounts are laid before the
      Company.
 13   To authorise the Audit and Risk Committee to determine the fees payable to the  203,417,776  99.99  2,527             0.01   5,401             81.37
      auditor.
 14   That, in accordance with section 551 of CA 2006, the Directors be generally     192,911,204  94.84  10,502,123        5.16   12,377            81.37
      and unconditionally authorised to allot Equity Securities within the
      parameters set out in the Notice.
 15*  That, subject to resolution 14 being passed, the Directors be authorised to     192,714,837  94.74  10,694,689        5.26   16,178            81.36
      allot Equity Securities for cash as if section 561 of the CA 2006 did not
      apply within the parameters set out in the Notice.
 16*  That, subject to resolution 14 being passed and in addition to resolution 15,   187,818,447  92.33  15,591,480        7.67   15,777            81.36
      the Directors be authorised to allot Equity Securities as if section 561 of
      the CA 2006 did not apply within the parameters set out in the Notice.
 17*  That the Company be authorised to make market purchases of Ordinary Shares      202,302,357  99.99  4,568             0.002  1,118,779         80.92
      within the parameters and on the terms set out in the Notice.
 18*  That the Company be authorised to hold general meetings (other than annual      203,325,255  99.95  96,239            0.05   4,210             81.37
      general meetings) on not less than 14 days' notice (see Notice).
 * special resolution

 

For the purposes of the FCA Listing Rules, Thomas Ryder and Steven Granite are
controlling shareholders as a result of their holding collectively 100,170,095
shares (85,662,494 and 14,507,601 respectively), representing 40% (34% and 6%,
respectively) of the total voting rights in the Company. Each resolution to
elect independent non-executive directors (resolutions 5, 6, 8, and 11) have
under UK Listing Rule 6.2.8 been approved by a majority of the votes cast by:
(i) the shareholders of the Company as a whole; and (ii) the independent
shareholders of the Company, that is, all the shareholders entitled to vote on
each resolution excluding the controlling shareholders, as set out in the
table below.

 No.  Resolution                                                    For                 Against                 Votes Withheld    Total issued share capital instructed

      Number of shares                                                           %      Number of shares  %     Number of shares  %
 5    To elect Tony Buffin as a director of the Company.            101,806,465  98.62  1,423,111         1.38  26,033            41.29
 6    To elect Peter Cowgill as a director of the Company.          100,912,892  98.35  1,696,823         1.65  645,894           41.04
 8    To elect Marnie Millard as a director of the Company.         101,726,715  98.54  1,510,794         1.46  18,100            41.30
 11   To elect Deepti Velury Bakhshi as a director of the Company.  103,230,574  99.99  7,336             0.01  17,699            41.30

 

Notes:

Any proxy appointments giving discretion to the Chairman of the meeting have
been included in the "For" total.

A vote "Withheld" is not a vote in law and is not counted in the calculation
of the votes "For" or "Against" a resolution.

The Company's total number of ordinary shares in issue as at 6:00 p.m. on 6
January 2026, being the time at which a person had to be registered in the
Company's register of members in order to be eligible to vote at the AGM, was
250,000,000 ordinary shares of £0.0002 each, with no shares held in treasury.
Shareholders are entitled to one vote per ordinary share held. Total voting
rights as at 6:00 p.m. on 6 January 2026 were therefore 250,000,000.

A copy of this announcement, will shortly be available on the Company's
website at https://www.appliednutritionplc.com/regulatory-news/
(https://www.appliednutritionplc.com/regulatory-news/) and on the FCA's
national storage mechanism at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

For further information please contact:

 Applied Nutrition plc                                                          Via Alma

 Thomas Ryder, Chief Executive Officer

Steven Granite, Chief Operating Officer

Joe Pollard, Chief Financial Officer
 Alma Strategic Communications (Public Relations adviser to Applied Nutrition)  T:  +44 (0) 203 405 0205

 Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters               appliednutrition@almastrategic.com

Notes to editors

Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and
wellness brand, which formulates and creates nutrition products with a stated
aim of being the world's most trusted and innovative brand in the market.

Headquartered in the UK, the Group sells products in over 85 countries
worldwide and has a diverse product range, targeting elite athletes, gym goers
and health-conscious consumers. Applied Nutrition has developed and launched
four ranges under the umbrella of the Applied Nutrition brand - Applied
Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group
sells over 100 different products.

Applied Nutrition's growth is fuelled by a market-leading product portfolio,
created and largely manufactured in-house at its Knowsley, Liverpool
headquarters by a team of industry experts. This end-to-end capability allows
the Group to innovate at speed, refresh and enhance existing products and
introduce new offerings that anticipate and respond to the latest consumer
trends.

Applied Nutrition largely operates a global business-to-business (B2B) model,
which has facilitated a low risk, highly cost-effective go-to-market strategy
and has enabled strong, profitable growth in the UK, Europe and other
international geographies. The business model and strategy has enabled the
Group to become a fast-growing, highly profitable and cash generative global
supplier in the sports nutrition, health and wellness market.

For further information, please visit www.appliednutritionplc.com
(https://www.appliednutritionplc.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBPMJTMTTMBAF



            Copyright 2019 Regulatory News Service, all rights reserved